The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: A cross-sectional comparison of established screening tools in a German-Swiss population

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 16, Issue 1-2, 2015, Pages 16-23

  Lulé, Dorothée ^a   Burkhardt, Christian ^b   Abdulla, Susanne ^c,d   Böhm, Sarah ^a   Kollewe, Katja ^c   Uttner, Ingo ^a   Abrahams, Sharon ^e   Bak, Thomas H ^e   Petri, Susanne ^c   Weber, Markus ^b   Ludolph, Albert C ^a  

^a UNIVERSITY OF ULM   (Germany)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis (ALS); Cognition; ECAS; Validation

Indexed keywords

ADULT; AGE; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BEHAVIOR CHANGE; CAREGIVER; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; CONCURRENT VALIDITY; CONSORTIUM TO ESTABLISH A REGISTRY ALZHEIMER DISEASE PLUS SCALE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDINBURGH COGNITIVE AND BEHAVIOURAL AMYOTROPHIC LATERAL SCLEROSIS SCREEN; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; FRONTAL ASSESSMENT BATTERY; GERMAN (CITIZEN); GERMANY; HUMAN; LANGUAGE; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MONTREAL COGNITIVE ASSESSMENT; NEUROLOGIC DISEASE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RATING SCALE; SENSITIVITY AND SPECIFICITY; SWITZERLAND; UNITED KINGDOM; VERBAL FLUENCY; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; REPRODUCIBILITY; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; GERMANY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; SWITZERLAND;

EID: 84925681820     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2014.959451     Document Type: Article

References (34)

1. Ludolph AC, Langen KJ, Regard M, Herzog H, Kemper B, Kuwe r t T, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand. 1992; 85: 81-9.
2. Mitsuyama Y. Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases. J Neurol Neurosurg Psychiatry. 1984; 47: 953-9.
3. Wikström J, Paetau A, Palo J, Sulkava R, Haltia M. Classic amyotrophic lateral sclerosis with dementia. Arch Neurol. 1982; 39: 681-3.
4. Ziegler LH. Psychotic and emotional phenomena associated with amyotrophic lateral sclerosis. Arch NeurPsych. 1930; 24: 930-6.
5. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314: 130-3.
6. Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, et al. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a Population-Based Case-Control Cohort Study of Familial and Sporadic Amyotrophic Lateral Sclerosis. Ann Neurol. 2013; 74: 699-708.
7. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011; 72: 257-68.
8. Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013; 12: 368-80.
9. Raaphorst J, de Visser M, Linssen WH, de Haan RJ, Schmand B. The cognitive profile of amyotrophic lateral sclerosis: a meta-analysis. Amyotroph Lateral Scler. 2010; 11: 27-37.
10. Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2012; 83: 102-8.
11. Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009; 10: 131-46.
12. Bak TH, Hodges JR. Motor neuron disease, dementia and aphasia: coincidence, co-occurrence or continuum? J Neurol. 2001; 248: 260-70.
13. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005; 65: 586-90.
14. Gibbons ZC, Richardson A, Neary D, Snowden JS. Behaviour in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008; 9: 67-74.
15. Brettschneider J, Del Tredici K, Irwin DJ, Grossman M, Robinson JL, Toledo JB, et al. Sequential distribution of pTDP-43 pathology in behavioural variant frontotemporal dementia (bvFTD). Acta Neuropathol. 2014; 127: 423-39.
16. Floris G, Borghero G, Chiò A, Secchi L, Cannas A, Sardu C, et al. Cognitive screening in patients with amyotrophic lateral sclerosis in early stages. Amyotroph Lateral Scler. 2012; 13: 95-101.
17. Osborne RA, Sekhon R, Johnston W, Kalra S. Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2014; 336: 191-6.
18. Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grise D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000; 38: 734-47.
19. Flaherty-Craig C, Eslinger P, Stephens B, Simmons Z. A rapid screening battery to identify frontal dysfunction in patients with ALS. Neurology. 2006; 67: 2070-2.
20. Gordon PH, Wang Y, Doorish C, Lewis M, Battista V, Mitsumoto H, Marder K. A screening assessment of cognitive impairment in patients with ALS. Amyotroph Lateral Scler. 2007; 8: 362-5.
21. Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, et al. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioural Screen (ALS-CBS). Amyotroph Lateral Scler. 2010; 11: 303-11.
22. Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014; 15: 9-14.
23. Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 293-9.
24. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53: 695-9.
25. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000; 55: 1621-6.
26. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull. 1988; 4: 642-52.
27. Cohen JA. A coefficient of agreement for nominal scales. Educational and Psychological Measurement. 1960; 20: 37-46.
28. Hallgren. Computing inter-rater reliability for observational data: an overview and tutorial. Tutor Wuant Methods Psychol. 2012; 8: 23-34.
29. Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Eurals Consortium. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009; 10: 310-23.
30. LuléD, Ehlich B, Lang D, Sorg S, Heimrath J, Kübler A, et al. Quality of life in fatal disease: the flawed judgment of the social environment. J Neurol. 2013; 260: 2836-43.
31. Bak TH. Learning from history: FTD, ALS and behaviour. Rinsho Shinkeigaku. 2010; 50: 1013.
32. Raaphorst J, Beeldman E, Jaeger B, Schmand B, van den Berg LH, Weikamp JG, et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. Is the Frontal Assessment Battery reliable in ALS patients? Amyotroph Lateral Scler. 2013; 14: 73-4.
33. Raaphorst J, Beeldman E, Jaeger B, Schmand B, van den Berg LH, Weikamp JG, et al. Response to 'Exploring limits of neuropsychological screening in ALS: The FAB problem'. Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14: 159-60.
34. Tremolizzo L, Ferrarese C, Appollonio I. Exploring limits of neuropsychological screening in ALS: the FAB problem. Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14: 157-8.